Department of Microbiology and Immunology,
University of North Dakota School of Medicine and Health Sciences,
Grand Forks, North Dakota 58202-9037
 |
INTRODUCTION |
To synthesize or modify its
peptidoglycan cell wall, Escherichia coli maintains 12 penicillin binding proteins (PBPs), most of which have no demonstrable
physiological purpose. Although each of these enzymes mediates one or
more known biochemical reactions, most are not essential because
E. coli survives without them (8). Traditionally, these proteins are separated into two subfamilies, only
one of which contributes to cell survival. The high-molecular-weight (HMW) PBPs (PBPs 1a, 1b, 1c, 2, and 3) are bifunctional
transglycosylase/transpeptidases or monofunctional transpeptidases
which synthesize and incorporate individual peptidoglycan strands into
the murein sacculus (9, 10, 19, 26). Each of these HMW
PBPs except PBP 1c has a defined physiological function (19, 26,
27, 29, 30). In contrast, the functions of the seven
low-molecular-weight (LMW) PBPs remain enigmatic (3, 8,
13).
The LMW PBPs (PBPs 4, 5, 6, and 7, DacD, AmpC, and AmpH) are subdivided
into four enzymatic classes: three monofunctional DD-carboxypeptidases, PBP 5, PBP 6, and DacD; one
bifunctional DD-carboxypeptidase/DD-endopeptidase, PBP 4;
one DD-endopeptidase, PBP 7; and two class C
-lactamases, AmpC and AmpH (3, 12-14, 17, 24). Among
these, the DD-carboxypeptidases have been studied most
extensively, but a cohesive picture of their in vivo roles has yet to
be established. PBPs 4, 5, and 6 and DacD cleave the terminal
D-alanine from the pentapeptide side chains of murein components (3). The considerable sequence identities and
structural similarities among these proteins suggest that they all
diverged from an ancient DD-carboxypeptidase, with
subsequent additions and modifications of specific functional domains
(16, 21).
These similarities and genetic data have led to the widespread
assumption that the DD-carboxypeptidases act as functional equivalents in vivo, so that these multiple carboxypeptidases may
compensate for one another in situations where one is lost or
inactivated (3, 5). Unfortunately, this "equivalent
substitution" hypothesis has been difficult to test because these
proteins are not essential for bacterial survival. For example, a
quadruple mutant grows normally even though it lacks PBPs 4, 5, and 6 and DacD (3, 8), and mutants lacking all seven LMW PBPs
grow well (8). However, there is a small amount of
evidence for differences among the LMW PBPs. As discussed in more
detail below, morphological defects accompany the loss of PBP 5 but of
no other PBP (22). Also, deletion of the dacA
gene (encoding PBP 5) substantially reverses the filamentation
phenotype of a temperature-sensitive ftsK allele, whereas
deletion of dacB (encoding PBP 4) or dacC (encoding PBP 6) does not (4). In addition, overexpression of either PBP 5 or PBP 6, but not PBP 4, reverses the effects of a
specific temperature-sensitive allele of PBP 3 (5),
implying that PBPs 5 and 6 (but not 4) might perform similar functions in vivo. Finally, it has been reported that although overexpression of
PBP 5 causes E. coli to become spherical and eventually lyse (18), PBP 4, PBP 6, and DacD are nonlethal (3, 17,
33), suggesting that these latter PBPs might differ from PBP 5. Because so few of these types of observations have been made, the idea of universal interchangeability among these proteins persists in the
literature and minds of many workers, and none of the observations has
brought us closer to understanding what these PBPs are doing. In short,
the paucity of testable phenotypes has limited experimental approaches
to the question of the biological function of the LMW PBPs.
Recently, we reported that PBP 5 helps maintain normal cell wall
morphology and diameter in E. coli (22). By
comparing isogenic mutants, we determined that no other LMW PBP could
substitute for PBP 5 to correct these defects in vivo at wild-type
expression levels. In this report we compare additional isogenic mutant
strains to determine the minimum complement of PBP deletions necessary to generate the morphological defects. We also show that no other DD-carboxypeptidase can complement the
dacA phenotype in trans, nor can a PBP 5 protein lacking its carboxy-terminal amphipathic membrane anchor.
Finally, we establish that overexpressing each of the
DD-carboxypeptidases does lyse host cells and show that such lysis occurs only during early logarithmic growth. Collectively, the results place constraints on the equivalent substitution hypothesis for the LMW PBPs and allow us to propose a speculative mechanism by
which these proteins contribute to the maintenance of uniform cell
shape in E. coli.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
The E. coli strains used in this work are listed in Table
1. Strains carrying the dacD
insertion-deletion mutation were constructed by moving
dacD::Kan536-2 from CS18-2K (8) into
the indicated strains by P1 transduction (20). Plasmid
vectors pBAD18-Cam and pBAD24-Amp were provided by J. Beckwith
(11). Bacterial strains were maintained on Luria-Bertani
(LB) broth or agar plates, supplemented when appropriate with
chloramphenicol (20 µg/ml) or ampicillin (50 µg/ml) to maintain
plasmids or with glucose (0.1%) to inhibit expression from pBAD
promoters. Overnight cultures for morphological determinations were
diluted 1:500 into fresh LB broth supplemented with 0.005 to 0.1%
(wt/vol) arabinose and were incubated at 37°C with shaking until
reaching an A600 of approximately 0.2. When
required, aztreonam (Bristol Meyers-Squibb, New York, N.Y.) was added
to a final concentration of 10 µg/ml. Other chemicals were purchased
from Sigma Chemical Co. (St. Louis, Mo.) unless otherwise noted. Growth
curves for determining lysis after overexpression of PBPs and for
comparisons of growth rates were performed in flask assays and by
growth in a Bioscreen C Microbiology Reader (Labsystems, Helsinki,
Finland).
Microscopic evaluation of morphological aberration.
To
compare the relative morphologies of the different E. coli
strains, cultures were diluted to an A600 of
0.005 and grown in LB at 37°C, and samples were removed during early
logarithmic growth phase (A600 = 0.2 ± 0.02). Photographs were collected from random microscopic fields as
described previously (22), and cell populations were
evaluated by two to three individuals for the degree of morphological
aberration. In our earlier work we could measure and quantify
alterations in cell diameter (22). However, the
morphological differences that we observed in this study did not lend
themselves to straightforward quantification. Therefore, the results
are expressed as a subjective measure of relative morphological
aberration based on differences in the numbers of cells affected and
the degree to which they exhibited increased diameters, uneven
contours, squaring of the poles, lateral branching, and filamentation.
The extent of these differences is reported on a relative scale of 0 (no observable differences from the parental strain) to 4 (numerous and
extreme shape differences).
Molecular and biochemical techniques.
Plasmid preparations
and DNA isolation from agarose gels were performed with commercially
available kits from Qiagen (Valencia, Calif.). Competent strains were
prepared and transformed by using a Bio-Rad (Hercules, Calif.) Gene
Pulser electroporation apparatus according to the manufacturer's
instructions. Chromosomal DNA was isolated as described previously
(22). Oligonucleotides for PCR were purchased from Gibco
Life Sciences (Grand Island, N.Y.). PBP expression was confirmed by
using sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) followed by silver staining (25) or by labeling
the PBPs with 125I-penicillin X as described previously
(13). The amounts of PBPs produced were quantified by
imaging SDS-PAGE gels with a Molecular Dynamics 445SI PhosphorImager
(Amersham Pharmacia, Uppsala, Sweden) and measuring band intensities by
using ImageQuant software (Amersham Pharmacia, Uppsala, Sweden).
Enzymes and reagents were purchased from New England Biolabs (Beverly,
Mass.).
Placing PBP genes under control of the arabinose promoter.
Primers B1 (5'-CTCTCTCTGAATTCTTATGCGATTTTCCAG-3') and B2
(5'-CTCTCTCTCTAGACTTTTTGACTAATTGTTCTG-3') were used to PCR
amplify the dacB (PBP 4) gene from the CS109 chromosome. The
EcoRI-XbaI fragment of this PCR product was
ligated into pBAD24-Amp to create plasmid pPJ4-Amp. Afterwards, the
NheI-XbaI fragment was excised from pPJ4-Amp and
ligated into pBAD18-Cam, creating the PBP 4 expression vector, pPJ4.
Primer pairs C1
(5'-CTCTTTTGCTAGCAGGAGGAATTCACCATGACGCAATACTCCTCTC-3') plus
C2 (5'-CTCTCTCTCTAGAAGAAGAATTAGAGAACCAGCTGC-3') and D1
(5'-CTCTCTCGCTAGCAGGAGGAATTCACCATGCTGTTGAAACGCCGTC-3') plus
D2 (5'-CCCCCCCTCTCAGATCTGCAAAAGAAAGGTCAGGCCTTATG-3') were used to PCR amplify the wild-type genes dacC and
dacD, respectively, from the CS109 chromosome. The
NheI-XbaI fragments of the dacC and
dacD PCR products were ligated into pBAD18-Cam to create the PBP expression vectors pPJ6 and pPJDacD, respectively. Primers E1
(5'-CGCGGCGGCTAGCAGGAGGAATTCGTCATGAATACCATTTTTTCCGC-3')
and E2
(5'-CCAAGGATTCTAGAAGCTTTTTTTAGTTACCTTCCGGGATTTC-3') were
used to PCR amplify a truncated fragment of the dacA gene
from the PBP 5 expression vector pPJ5C (22). This fragment
encoded the full-length PBP 5 protein minus the 54 3'-terminal
nucleotides of the dacA coding sequence, so that the
C-terminal amphipathic anchor of PBP 5 was deleted. The
NheI-XbaI fragment of this PCR product was
ligated into pBAD18-Cam, creating plasmid pPJ5D. pPJ5S was constructed
by using a Stratagene QuickChange site-directed mutagenesis kit and
primers F1 (5'-CGCCGCGATCCTGCCGGCCTGACCAAAATGATG-3') and F2
(5'-CATCATTTTGGTCAGGCCGGCAGGATCGCGGCG-3'), with pPJ5C as the
template (Stratagene Co., La Jolla, Calif.). All clones were sequenced
commercially at Colorado State University using the ABI Prism
Terminator Cycle Sequencing technique (Fort Collins, Colo.).
 |
RESULTS |
Previously, we began to determine which PBPs were necessary to
maintain the normal morphology of E. coli by comparing
isogenic strains that retained only one or two active LMW PBPs, in
mutants from which six to seven PBP genes had been deleted
(22). Although loss of PBP 5 was the primary determinant
of aberrant morphology, deletion of dacA alone had little
effect on the wild-type strain (22). Thus, it was possible
that an unknown combination of different PBPs could take the place of
PBP 5. Therefore, to further clarify the role of PBP 5, and to
determine the minimum complement of deletions necessary to yield the
morphological phenotype, we examined the morphology of 41 single,
double, and triple PBP mutants from our comprehensive PBP mutant set
(8).
Morphological defects are associated with deletion of
dacA.
In agreement with previous findings
(22), no significant morphological defects were associated
with loss of a single PBP (data not shown). In particular, the
dacA mutant, CS12-7, showed no significant differences from
the wild-type strain, CS109 (Table 2;
Fig. 1A and B), and though a few
aztreonam-induced filaments of CS12-7 were slightly rounded or
branched, the numbers were too small to quantify (data not shown). Of
special importance was that no double or triple mutant in which PBP 5 remained active exhibited significant morphological oddities (data not
shown), once again implicating PBP 5 as the dominant determinant for
this phenotype.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 1.
Morphology of PBP mutants of E. coli.
Overnight cultures of E. coli strains were diluted 1:500
into fresh LB broth and grown at 37°C until reaching an
A600 of 0.2. Cells were collected, prepared for
microscopy, and photographed at a magnification of ×1,000. All
photographs are displayed at equal magnification. Abbreviations: 4, PBP
4; 5, PBP 5; 6, PBP 6; 7, PBP 7; C, AmpC; wt, wild-type parent.
|
|
Although deletion of PBP 5 alone had little effect on cellular
morphology, observable defects were augmented by loss of additional PBPs. The differences among mutants lacking PBP 5 were assessed subjectively by inspection of multiple photographs of cell cultures, and the strains were organized according to their relative degree of
morphological aberration (Table 2). Because of their subjective nature,
these rankings should be considered as a rough guide to the degree of
morphological differences between strains. Nonetheless, large
differences in scoring (>2 units) do depict significant differences in
the frequency and/or degree of cell shape aberrations.
The mutants exhibiting the most dramatic morphological defects were
those lacking PBPs 5 and 6 and either PBP 4 or PBP 7 (strains CS322-1
and CS331-1, respectively) (Table 2; Fig. 1C and D). On the other hand,
the morphology of strain CS316-1, which is missing PBPs 4, 6, and 7 (described as
467), was nearly normal (Table 2; Fig. 1E),
underscoring the importance of PBP 5 for this phenotype. This
combination, loss of PBP 5 and at least one endopeptidase (PBP 4 or 7),
correlated most strongly with overall morphological aberration. Eight
of the 11 strains displaying abnormalities greater than 2 on the
relative scale were missing PBP 5 and one of the endopeptidases, and 12 of the 17 strains scoring 1.5 or greater contained this combination of
deletions. Of the 15 strains lacking PBP 5 and either PBP 4 or PBP 7, only three were of normal shape (scores below 1) (Table 2). The five
strains scoring 1.5 or greater and which did not fit this pattern were
missing PBP 5 and either AmpC or AmpH (or both), consistent with what
we reported previously (13). Thus, two mutant combinations
accounted for the most extreme morphological alterations: deletion of
PBP 5 and an endopeptidase (PBP 4 or 7), which provoked the greatest deviations from normal morphology, followed in degree by deletion of
PBP 5 plus one of the class C
-lactamases (AmpC or AmpH).
The data reinforced the primary role for PBP 5 in creating
morphologically uniform cells. For example, strain CS362-1 (
1a 5 AmpC) was unable to maintain an even contour, had drastic alterations in diameter, and produced increased numbers of branched cells (Fig.
1F). In contrast, its isogenic relatives CS361-1 (
1a 4 AmpC) and
CS363-1 (
1a 6 AmpC) retained near-wild-type morphology (Fig. 1G and
H). In these latter two strains, PBPs 4 and 6 were deleted instead of
PBP 5, confirming that the loss of neither of these proteins created
the same morphological aberrations as did loss of PBP 5. Nor did the
presence of PBPs 4 or 6 substitute for the absence of PBP 5 in CS362-1.
Similarly, though CS346-1 (
5 7 AmpC) exhibited morphological
defects, two isogenic relatives, CS318-1 (
4 7 AmpC) and CS343-1
(
6 7 AmpC), had wild-type morphology (Table 2). As before, deletion
of PBP 5, but not PBP 4 or 6, provoked the aberrations. Comparisons of
other strains yielded the same results for the activity of PBP 5 versus
all other PBPs. Thus, although the absence of additional LMW PBPs
augmented the morphological defects of dacA mutants, in the
presence of active PBP 5, these other PBPs could not precipitate such
defects when deleted individually or in combination.
Only PBP 5 complements the morphological defects of
dacA mutants.
The preceding experiments addressed the
question of whether wild-type levels of different LMW PBPs could
substitute for PBP 5. It remained possible that these other PBPs might
complement the loss of PBP 5 if they were expressed in higher
quantities. Therefore, to determine which of E. coli's
DD-carboxypeptidases could complement the morphological
defects of dacA mutants, we cloned the dacB,
dacC, and dacD genes of wild-type strain CS109 into the
arabinose-inducible expression vector pBAD18-Cam (11). The
PBP subclones were transformed into CS109 and into the septuple PBP
mutant CS701-1, and the viability of each strain was evaluated across a
range of arabinose concentrations (0.1 to 0.0001%) using a Bioscreen C
Microbiology Reader to determine the most effective inducing conditions
(data not shown). Final arabinose concentrations for gene induction and
complementation studies were selected by comparing the growth rates of
cells harboring the PBP expression vectors to those of identical
strains containing the control vector pBAD18-Cam, supplemented by
subjective visual assessment of morphology.
Cells were photographed during log-phase growth and again 45 min after
treatment with aztreonam (10 µg/ml) to enhance any morphological
aberrations by filamenting the cells. As reported previously
(22), E. coli CS604-2(pBAD18-Cam), which lacks
six PBPs but retains wild-type dacA, was morphologically
similar to wild-type E. coli (Fig.
2A). In contrast,
CS701-1(pBAD18-Cam), which is isogenic to
CS604-2(pBAD18-Cam) but lacks the dacA gene, exhibited
drastic alterations in morphology both before and after filamentation
induced by aztreonam (Fig. 2B). Regulated expression of PBP 5 in
CS701-1(pPJ5C) reversed these defects, and the complemented strain
was visually indistinguishable from CS604-2(pBAD18) (Fig. 2C). In
contrast, expression of cloned PBP 4 (Fig. 2D), PBP 6 (Fig. 2E), or
DacD (Fig. 2F) did not complement the morphological defects of CS701-1
at any level of expression. In fact, in most cases the severity of the
morphological defects in CS701-1 was exacerbated by expression of these
non-PBP 5 DD-carboxypeptidases (Fig. 2D to F).

View larger version (106K):
[in this window]
[in a new window]
|
FIG. 2.
Complementation of PBP mutants by
DD-carboxypeptidases. E. coli strains containing
plasmids with or without cloned PBP genes were diluted 1:500 from
overnight cultures into fresh LB broth supplemented with arabinose
(0.005%, wt/vol) and were incubated at 37°C. When the cultures
reached an A600 of 0.2, aztreonam was added to a
final concentration of 10 µg/ml. Cells were photographed immediately
before (Log) and 45 mins after (+ Aztreonam) aztreonam addition. All
photographs are displayed at equal magnification. Abbreviations:
vector, pBAD18-Cam; anchor, truncated PBP 5 missing the
carboxy-terminal 18 amino acids; S44G, PBP 5 with serine-to-glycine
substitution at amino acid 44, inactivating the active site.
|
|
Both the active site and membrane anchoring terminus of PBP 5 are
required for complementation.
PBP 5 has three known domains: one
containing the DD-carboxypeptidase activity, one
responsible for localizing PBP 5 to the outer face of the cytoplasmic
membrane, and a third domain of unknown function between these other
two (7, 15, 23, 34). To determine if the enzymatic and
membrane-binding activities were necessary to complement the
morphological phenotype of dacA mutants, we constructed
vectors to express mutant PBP 5 proteins in which one or the other of
these two domains was inactivated. Plasmid pPJ5D expressed a truncated
mutant protein lacking the carboxy-terminal 18 amino acids that anchor
PBP 5 to the membrane. Plasmid pPJ5S expressed a full-length PBP 5 in
which a Ser44-to-Gly44 mutation eliminated the protein's
DD-carboxypeptidase activity (34).
Truncated PBP 5 expressed from pPJ5D was unable to complement the
morphological defects of CS701-1, either before or after treatment with
aztreonam (Fig. 2G). In fact, even low-level expression of the
truncated protein was lethal or actually augmented the morphological
abnormalities observed in these cells, indicating that membrane
association of PBP 5 is important for its proper functioning in vivo.
Similarly, enzymatically inactive PBP 5 encoded by pPJ5S was unable to
complement the defects in CS701-1 (Fig. 2H), indicating that the
DD-carboxypeptidase activity was essential for creating
morphologically normal cells.
All DD-carboxypeptidases are lytic when overexpressed
early in the growth phase.
While performing complementation
studies, we noted that prolonged expression of each of the
DD-carboxypeptidases decreased the viability of
fast-growing cultures, but that this effect diminished in slow-growing
or stationary-phase cells. However, previous reports suggested that
only PBP 5 induced lysis when overexpressed. Therefore, to clarify the
differences between our observations and previous experiments, we
overexpressed each of the DD-carboxypeptidases in E. coli CS109. All active DD-carboxypeptidases lysed
CS109 within 2 h of gene induction in flask assays (Fig.
3A), and viable cell counts in these
cultures dropped 2 logs within 2 h of protein induction (data not
shown). The onset of lysis in cultures grown in the Bioscreen C
Microbiology Reader was delayed and the rate of lysis was reduced, but
the results were similar in that all of the
DD-carboxypeptidases lysed E. coli (Fig. 3B). In
each case, the microscopic effects of overexpressing the
carboxypeptidases were similar: cells grew normally for a brief period
then rapidly became spherical and lysed shortly thereafter (data not
shown). This is consistent with the effects previously described for
PBP 5 (28). Lysis, but not lethality, was inhibited by
addition of 15% sucrose to osmotically stabilize the labile
spheroplasts, and lysis did not occur if protein synthesis was
interrupted by adding tetracycline (12.5 µg/ml) 30 min after gene
induction (though lysis occurred normally if tetracycline was added 60 min after induction) (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Lysis of E. coli by
DD-carboxypeptidase overexpression. Overnight cultures of
E. coli CS109 containing plasmids with or without cloned PBP
genes were diluted 1:500 into fresh LB broth and incubated at 37°C in
flasks in a shaking water bath (A) or in the Bioscreen C
Microbiology Reader (B). When the A600 reached
0.2 (for flask cultures) or 0.15 (in the Bioscreen Reader), arabinose
(0.1%, wt/vol) was adding to induce PBP gene expression.
CS109(pBAD18), ; CS109(pPJ4), ; CS109(pPJ5C), ;
CS109(pPJ6), ; CS109(pPJDacD), .
|
|
Because these lysis phenotypes were at odds with those reported
previously, we examined possible reasons for the discrepancy. In the
earlier studies in which DD-carboxypeptidase overexpression failed to lyse E. coli, the proteins were not expressed
until cultures reached the mid or late logarithmic growth phase.
Therefore, to determine if lysis sensitivity was influenced by growth
phase, we induced the carboxypeptidases in cultures at different times in the growth cycle. Growth was monitored in the Bioscreen C
Microbiology Reader as before, but the genes were induced by adding
arabinose at time points corresponding to early, mid, and late log
phases. As cells progressed from early to late log phase, induction of the various PBPs had a decreasing lytic effect (Fig.
4). This was not because PBP expression
was reduced; indeed, in each case, high levels of PBPs were expressed
at these times, as determined by labeling the PBPs and visualizing them
by SDS-PAGE (data not shown). Thus, each of the
DD-carboxypeptidases was lytic when overexpressed, but cell
cultures were more sensitive to lysis during early logarithmic growth
and became increasingly resistant as they approached stationary phase.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of growth phase on lysis of E. coli by
overexpression of DD-carboxypeptidases. E. coli
CS109 was transformed with the following plasmids carrying the
indicated PBPs under control of the arabinose promoter: (A) pPJ5C, PBP
5; (B) pPJ4, PBP4; (C) pPJ6, PBP 6; and (D) pPJDacD, DacD. Overnight
cultures were diluted 1:500 into fresh LB broth and incubated at 37°C
in a Bioscreen C Microbiology Reader. PBP expression was induced at
three different times in the growth cycle by adding arabinose to a
final concentration of 0.1% (wt/vol). No arabinose, ; arabinose
added at an A600 of 0.15, ; arabinose added
at an A600 of 0.30, ; arabinose added at an
A600 of 0.60, .
|
|
Removal of the C-terminal membrane anchor increases lethality of
PBP 5.
That the membrane anchoring domain of PBP 5 may serve a
physiological purpose was suggested by the observation that the
carboxy-truncated form of PBP 5 did not complement CS701-1 and,
instead, apparently exacerbated morphological defects in the strain. In
light of these results, we wished to determine if the membrane anchor
affected the lytic activity of overexpressed PBP 5. Lysis of CS109 by
wild-type PBP 5 (from pPJ5) and lysis by carboxy-truncated PBP 5 (from
pPJ5D) were compared in flask assays (data not shown) and in the
Bioscreen C Microbiology Reader, using a gradient of arabinose
concentrations to induce different amounts of each cloned protein (Fig.
5). Although overexpression of truncated
PBP 5 did not appreciably reduce the time of lysis onset, lysis
required a substantially lower concentration of truncated PBP 5 than
wild-type PBP 5. A 7-fold overexpression of truncated PBP 5 lysed CS109
with kinetics that were comparable to a 65-fold overexpression of the
full-length protein (Fig. 5). Even a fourfold overexpression of
truncated PBP 5 was rapidly lethal (Fig. 5). Roughly speaking, compared
to the overexpression of wild-type PBP 5, only 1/10 of the amount of
truncated PBP 5 was required to induce a comparable amount and
extent of lysis.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Lysis of E. coli by overexpression of
wild-type or carboxy-terminal truncated PBP 5. Overnight cultures of
E. coli CS109 containing either pPJ5 (to express wild-type
PBP 5) or pPJ5D (to express PBP 5 lacking the carboxy-terminal membrane
anchor) were diluted 1:500 into fresh LB broth and incubated with
shaking in flasks at 37°C to an A600 of 0.2. At that point, arabinose was added at different final concentrations to
induce different levels of PBP expression. Samples for PBP
quantification were collected before and 30 mins after induction of
protein expression, and the amounts of wild-type and truncated PBP 5 expressed from equal numbers of cells were quantified by comparing the
intensities of PBP bands after separation by SDS-PAGE. The amount of
wild-type PBP 5 expressed from a single chromosomal copy of the
dacA gene was regarded to be the 1× expression level, and
amounts of overexpression of the wild-type and truncated PBP 5 forms
are expressed as multiples of this baseline figure. PBP 5 (1×
expression), ; PBP 5 (12× expression), ; PBP 5 (65×
expression), ; carboxy-truncated PBP 5 (4× expression), ;
carboxy-truncated PBP 5 (7× expression), .
|
|
 |
DISCUSSION |
Despite 25 years of work, little is known about the
biologically relevant roles of the DD-carboxypeptidase PBPs
in E. coli. Previously, we noted that deletion of PBP 5 altered the antibiotic resistance and morphology of several PBP mutants
(22), representing the first phenotype associated with the
loss of one of the DD-carboxypeptidases in an otherwise
wild-type background. These observations enabled us to perform a direct
test of the idea that several of these proteins have similar or
identical functions, an idea that we call the equivalent substitution
hypothesis. To date, little or no evidence contradicts this assertion
of interchangeability (with the possible exception of two reports
describing the effects of DD-carboxypeptidases on non-PBP
mutants [4, 5]). Our findings indicate that PBP 5 has a
unique role among the DD-carboxypeptidases in the
development of normal bacterial shape and that no other PBP can
completely substitute for PBP 5 in this regard.
PBP mutant combinations and abnormal morphology.
Although all
strains with morphological abnormalities lacked PBP 5, the extent of
deviation in diameter, contour, branching, and other defects varied
greatly among mutants from which PBP 5 was deleted. The most dramatic
aberrations appeared in cells lacking at least two additional PBPs and
were correlated with two prominent combinations of mutations: deletion
of PBP 5 and one of the endopeptidases (PBP 4 or 7), or deletion of PBP
5 and one of the class C
-lactamases (AmpC or AmpH). The most
significant effects were in cells lacking PBP 5 and either PBP 4 or PBP
7 in combination with a deletion of either PBP 6 (in strains exhibiting the greatest alterations) or DacD, suggesting that active PBP 6 or DacD
might moderate the morphological effects of losing PBP 5. Since these
latter two enzymes are those most closely related to PBP 5, the results
may be consistent with a weak form of the substitution hypothesis in
which PBP 6 or DacD might perform some of the functions of PBP 5 with
lower efficiency.
An important observation was that the mutational patterns associated
with altered morphology were strongly correlated with the classical
groupings of PBPs based on sequence similarity and biochemical
activity; that is, the DD-carboxypeptidases,
endopeptidases, and class C
-lactamases. This is a credible
indication that similar enzymes may perform similar functions within
the cell. However, it is clear that no one enzyme can carry out all of
the physiological functions of the other members in its group. For
example, deletion of either PBP 4 or PBP 7 from a mutant lacking PBPs 5 and 6 produces remarkable morphological effects, even though one or the
other of the endopeptidases remains active. The same can be said of PBP
5 mutants lacking one or the other of the class C
-lactamases (AmpC
or AmpH). Thus, for each biochemical group, losing the activity of a
single PBP creates a noticeable phenotype, indicating that the enzymes
within each classification are not equivalent and do not simply
duplicate one another's functions. This is a compelling argument
against the strong form of the substitution hypothesis.
Possible model for PBP 5 action.
How might PBP 5 contribute to
the construction of a normally shaped cell? Theoretically, PBP 5 could
contribute a specific and necessary enzymatic activity or the protein
could be a structural component of a larger morphological complex
(although the two possibilities are not mutually exclusive). We
approached this question by creating two PBP 5 derivatives: one
enzymatically inactive, and the other truncated to remove its membrane
anchor. Neither derivative complemented dacA mutants,
suggesting that PBP 5 must be both enzymatically active and properly
localized to create the normal morphological form of E. coli. Although the data do not address whether PBP 5 acts in
concert with other proteins, they do diminish the possibility that PBP
5 acts solely as a structural protein.
This is the first demonstration that membrane localization of a LMW PBP
has physiological significance, because removal of the membrane anchor
prevented truncated PBP 5 from performing its normal morphological
function. An alternate explanation is that removing the carboxyl
terminus altered the enzymatic activity of PBP 5 so that losing the
membrane anchor had only an indirect effect. However, two pieces of
evidence argue against this interpretation. First, truncated PBP 5 retained the ability to bind radiolabeled penicillin, a property of the
active site and an indication that the enzymatic activity was
unchanged. Second, the shortened protein remained lethal when
overexpressed, a characteristic that also requires a functional
DD-carboxypeptidase. In fact, the lethality of anchorless
PBP 5 was increased approximately 10-fold over its wild-type
counterpart, suggesting not only that membrane localization of PBP 5 is
necessary for proper morphological control but that such localization
may regulate the numbers or types of substrates on which PBP 5 can act.
Given these results, there are at least two ways by which PBP 5 may
function. First, the carboxy-terminal membrane anchor may play a
relatively nonspecific role by restricting access of PBP 5 to its
peptidoglycan substrate; second, the membrane anchor may play a more
active role by interacting with proteins or specific regions of the
inner membrane to confine PBP 5's activity to localized sites. Since
there is no evidence for the second possibility, we will discuss only
the first possibility at more length.
The recent determination of the crystal structure of a truncated form
of PBP 5 (7) allows us to visualize a simple, speculative model by which the activity of PBP 5 might be constrained (Fig. 6). As reported by Davies et al. PBP 5 is
composed of a globular domain, which contains the
DD-carboxypeptidase active site on its outer face, and a
domain of unknown function, which is composed almost entirely of
sheets (7) (represented schematically in Fig. 6). These
two domains are connected so that they are oriented at right angles to
one another, forming a head (the globular active site) and a stalk (the
-sheet domain) (7). Although absent from crystallized
PBP 5, the extreme carboxy-terminal membrane-associated domain is
predicted to be located at the base of the stalk, where the amphipathic
helix could tether the protein to the outer face of the inner membrane
(Fig. 6). If positioned as shown, PBP 5 might hydrolyze only those
terminal D-alanine residues on peptide side chains that
extend toward the inner membrane while being unable to hydrolyze
residues on side chains in the plane of the cell wall or on the outer
face of the peptidoglycan (Fig. 6). In this scenario, removing the
membrane anchor may release PBP 5 from the membrane, allowing it to
diffuse freely throughout the periplasm with increased access to all
areas of the sacculus. This may explain the increased lethality of
small amounts of the truncated protein because unregulated
hydrolysis of normally protected side chains may prevent formation of
essential structural cross-links.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 6.
Speculative structure and orientation of PBP 5 in the
periplasm of E. coli. The schematic representation of PBP 5 (black inverted L-shaped form) is based on the crystal structure of PBP
5 as determined by Davies et al. (7). The
DD-carboxypeptidase active site is depicted as an
indentation in the predominately -helical head portion of the
molecule. The -helical stalk is connected to the head to form a
rough right angle, and the entire protein is tethered to the outer face
of the inner membrane by a carboxy-terminal 18-amino-acid amphipathic
helix (curved line). One peptidoglycan chain of
N-acetylglucosamine-N-acetylmuramic acid subunits
(horizontal dashes) is depicted. The peptide side chains attached to
the N-acetylmuramic acid residues are illustrated by short
lines extending above, below, or in the plane of the cell wall. As PBP
5 moves (arrow), the protein removes the terminal D-alanine
residue (D-ala) from peptide side chains extending toward
the inner membrane. Other side chains may be inaccessible to the normal
activity of PBP 5.
|
|
This speculative model suggests a mechanism by which PBP 5 might
maintain the smooth rod shape of the cell. In the absence of PBP 5, peptide side chains extending toward the inner membrane may remain
available for inappropriate cross-linking with newly synthesized glycan
chains, giving rise to misaligned sections of cell wall which manifest
themselves as altered shapes of the peptidoglycan sacculus. If present,
an endopeptidase (PBP 4 or 7) might remove these irregular cross-links,
thus reversing or masking the morphological effects of losing PBP 5. Such a two-step pathway would be consistent with the fact that the most
severely affected mutants lack PBP 5 and at least one of the
endopeptidases. Of course, we do not know enough to explain why one
endopeptidase cannot fulfill the role of the other, nor do we know
enough about AmpC or AmpH to fit them into this scheme. Although the
specifics of this putative morphological pathway must await further
experimentation, the results do reinforce the argument that bacterial
shape is not determined simply by general physical forces but that,
instead, cell shape is monitored and manipulated by specific cellular proteins.
Overexpression of any DD-carboxypeptidase lyses
E. coli.
As discussed above, excessive
DD-carboxypeptidase activity may inhibit formation of a
normal sacculus by interfering with the cross-linking of peptide side
chains. Previous work supports this hypothesis for PBP 5 because
overexpression of the protein causes E. coli to assume a
rounded morphology, blocks cell division, and eventually leads to lysis
after the cells grow to greatly increased diameters (17).
On the other hand, overexpression of PBPs 4 and 6 was reported to be
nonlethal (17, 18), and Baquero et al. reported no lysis
after overexpression of DacD (3). However, with the
exception of a single report calling the activity of PBP 6 into
question (33), it has been consistently reported that PBPs
4, 5, and 6 and DacD are active DD-carboxypeptidases (1-3). Therefore, why should only PBP 5 induce cell lysis?
In contrast to earlier reports, we observed that overexpression of each
of these other DD-carboxypeptidases was lethal and lytic.
The difference between our results and those reported by other
laboratories is most easily explained by the fact that in previous
experiments PBP 4, PBP 6, and DacD were expressed late in logarithmic
growth or near the beginning of stationary phase. However, we observed
that these PBPs lysed cells only if the proteins were overexpressed in
the early stages of logarithmic growth. This behavior is reminiscent of
the lytic effects of
-lactams, to which cells also become more
resistant as they grow slowly or as they approach stationary phase
(31, 32). This phenotypic resistance phenomenon has never
been explained on the molecular level, and it is unclear why the
DD-carboxypeptidases would be less lethal during late log
or stationary growth since peptidoglycan synthesis and turnover still
occurs at these times (6).
Biological relevance of the DD-carboxypeptidases.
The DD-carboxypeptidases are not essential for bacterial
viability (8), nor do they appear to completely substitute
for one another. Therefore, ignoring the possibility that novel
DD-carboxypeptidases remain undiscovered in E. coli, we entertain two scenarios which might explain the
difficulty of ascribing functions to these proteins. First, a
DD-carboxypeptidase activity may be essential in E. coli's normal ecological niche in the digestive tract of
vertebrates but unnecessary in the zoo-like environment of laboratory
culture. Thus, the phenotype could be subtle or undetectable except
under special conditions. Second, the enzymes might contribute an
incremental growth advantage to E. coli in the wild. In this
case, the significance of defects caused by inactivation of one or more
DD-carboxypeptidases might be overlooked. For example,
there are small, but definite, differences in growth rates among our
collection of multiple PBP mutants (unpublished results). Although a
1% difference in growth rate between two strains grown in flask
culture would probably be inconsequential in the laboratory, the
long-term selective advantage of such a difference in the wild can be significant.
We thank Avery Paulson for help in evaluating the extent of
morphological abnormalities among the mutants.
This work was supported by grant GM61019 from the National Institutes
of Health. D. Nelson was supported by a North Dakota EPSCoR doctoral
fellowship from the National Science Foundation.
| 1.
|
Amanuma, H., and J. L. Strominger.
1980.
Purification and properties of penicillin-binding proteins 5 and 6 from Escherichia coli membranes.
J. Biol. Chem.
255:11173-11180[Abstract/Free Full Text].
|
| 2.
|
Amanuma, H., and J. L. Strominger.
1984.
Purification and properties of penicillin-binding proteins 5 and 6 from the dacA mutant strain of Escherichia coli (JE11191).
J. Biol. Chem.
259:1294-1298[Abstract/Free Full Text].
|
| 3.
|
Baquero, M.-R.,
M. Bouzon,
J. C. Quintela,
J. A. Ayala, and F. Moreno.
1996.
dacD, an Escherichia coli gene encoding a novel penicillin-binding protein (PBP6b) with DD-carboxypeptidase activity.
J. Bacteriol.
178:7106-7111[Abstract/Free Full Text].
|
| 4.
|
Begg, K. J.,
S. J. Dewar, and W. D. Donachie.
1995.
A new Escherichia coli cell division gene, ftsK.
J. Bacteriol.
177:6211-6222[Abstract/Free Full Text].
|
| 5.
|
Begg, K. J.,
A. Takasuga,
D. H. Edwards,
S. J. Dewar,
B. G. Spratt,
H. Adachi,
T. Ohta,
H. Matsuzawa, and W. D. Donachie.
1990.
The balance between different peptidoglycan precursors determines whether Escherichia coli cells will elongate or divide.
J. Bacteriol.
172:6697-6703[Abstract/Free Full Text].
|
| 6.
|
Blasco, B.,
A. G. Pisabarro, and M. A. de Pedro.
1988.
Peptidoglycan biosynthesis in stationary-phase cells of Escherichia coli.
J. Bacteriol.
170:5224-5228[Abstract/Free Full Text].
|
| 7.
|
Davies, C.,
S. W. White, and R. A. Nicholas.
2001.
Crystal structure of a deacylation-defective mutant of penicillin-binding protein 5 at 2.3-Å resolution.
J. Biol. Chem.
276:616-623[Abstract/Free Full Text].
|
| 8.
|
Denome, S. A.,
P. K. Elf,
T. A. Henderson,
D. E. Nelson, and K. D. Young.
1999.
Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis.
J. Bacteriol.
181:3981-3993[Abstract/Free Full Text].
|
| 9.
|
Ghuysen, J.-M., and G. Dive.
1994.
Biochemistry of the penicilloyl serine transferases, p. 103-129.
In
J.-M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science B. V., Amsterdam, The Netherlands.
|
| 10.
|
Goffin, C., and J.-M. Ghuysen.
1998.
Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs.
Microbiol. Mol. Biol. Rev.
62:1079-1093[Abstract/Free Full Text].
|
| 11.
|
Guzman, L.-M.,
D. Belin,
M. J. Carson, and J. Beckwith.
1995.
Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter.
J. Bacteriol.
177:4121-4130[Abstract/Free Full Text].
|
| 12.
|
Henderson, T. A.,
M. Templin, and K. D. Young.
1995.
Identification and cloning of the gene encoding penicillin-binding protein 7 of Escherichia coli.
J. Bacteriol.
177:2074-2079[Abstract/Free Full Text].
|
| 13.
|
Henderson, T. A.,
K. D. Young,
S. A. Denome, and P. K. Elf.
1997.
AmpC and AmpH, proteins related to the class C -lactamases, bind penicillin and contribute to the normal morphology of Escherichia coli.
J. Bacteriol.
179:6112-6121[Abstract/Free Full Text].
|
| 14.
|
Höltje, J.-V.
1998.
Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli.
Microbiol. Mol. Biol. Rev.
62:181-203[Abstract/Free Full Text].
|
| 15.
|
Jackson, M. E., and J. M. Pratt.
1987.
An 18 amino acid amphiphilic helix forms the membrane-anchoring domain of the Escherichia coli penicillin-binding protein 5.
Mol. Microbiol.
1:23-28[CrossRef][Medline].
|
| 16.
|
Joris, B.,
J.-M. Ghuysen,
G. Dive,
A. Renard,
O. Dideberg,
P. Charlier,
J.-M. Frère,
J. A. Kelly,
J. C. Boyington,
P. C. Moews, and J. R. Knox.
1988.
The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family.
Biochem. J.
250:313-324[Medline].
|
| 17.
|
Korat, B.,
H. Mottl, and W. Keck.
1991.
Penicillin-binding protein 4 of Escherichia coli: molecular cloning of the dacB gene, controlled overexpression, and alterations in murein composition.
Mol. Microbiol.
5:675-684[CrossRef][Medline].
|
| 18.
|
Markiewicz, Z.,
J. K. Broome-Smith,
U. Schwarz, and B. G. Spratt.
1982.
Spherical E. coli due to elevated levels of D-alanine carboxypeptidase.
Nature
297:702-704[CrossRef][Medline].
|
| 19.
|
Matsuhashi, M.
1994.
Utilization of lipid-precursors and the formation of peptidoglycan in the process of cell growth and division: membrane enzymes involved in the final steps of peptidoglycan synthesis and the mechanism of their regulation, p. 55-71.
In
J.-M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science B. V., Amsterdam, The Netherlands.
|
| 20.
|
Miller, J. H.
1992.
A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria.
Cold Spring Harbor Laboratory Press, Plainview, N.Y.
|
| 21.
|
Mottl, H.,
P. Nieland,
G. de Kort,
J. J. Wierenga, and W. Keck.
1992.
Deletion of an additional domain located between SXXK and SXN active-site fingerprints in penicillin-binding protein 4 from Escherichia coli.
J. Bacteriol.
174:3261-3269[Abstract/Free Full Text].
|
| 22.
|
Nelson, D. E., and K. D. Young.
2000.
Penicillin binding protein 5 affects cell diameter, contour, and morphology of Escherichia coli.
J. Bacteriol.
182:1714-1721[Abstract/Free Full Text].
|
| 23.
|
Pratt, J. M.,
M. E. Jackson, and I. B. Holland.
1986.
The C terminus of penicillin-binding protein 5 is essential for localisation to the E. coli inner membrane.
EMBO J.
5:2399-2405[Medline].
|
| 24.
|
Romeis, T., and J.-V. Höltje.
1994.
Penicillin-binding protein 7/8 of Escherichia coli is a DD-endopeptidase.
Eur. J. Biochem.
224:597-604[Medline].
|
| 25.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 26.
|
Schiffer, G., and J.-V. Höltje.
1999.
Cloning and characterization of PBP 1C, a third member of the multimodular class A penicillin-binding proteins of Escherichia coli.
J. Biol. Chem.
274:32031-32039[Abstract/Free Full Text].
|
| 27.
|
Spratt, B. G.
1975.
Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12.
Proc. Natl. Acad. Sci. USA
72:2999-3003[Abstract/Free Full Text].
|
| 28.
|
Stoker, N. G.,
J. K. Broome-Smith,
A. Edelman, and B. G. Spratt.
1983.
Organization and subcloning of the dacA-rodA-pbpA cluster of cell shape genes in Escherichia coli.
J. Bacteriol.
155:847-853[Abstract/Free Full Text].
|
| 29.
|
Tamaki, S.,
H. Matsuzawa, and M. Matsuhashi.
1980.
Cluster of mrdA and mrdB genes responsible for the rod shape and mecillinam sensitivity of Escherichia coli.
J. Bacteriol.
141:52-57[Abstract/Free Full Text].
|
| 30.
|
Tamura, T.,
H. Suzuki,
Y. Nishimura,
J. Mizoguchi, and Y. Hirota.
1980.
On the process of cellular division in Escherichia coli: isolation and characterization of penicillin-binding proteins 1a, 1b, and 3.
Proc. Natl. Acad. Sci. USA
77:4499-4503[Abstract/Free Full Text].
|
| 31.
|
Tuomanen, E.
1986.
Phenotypic tolerance: the search for -lactam antibiotics that kill nongrowing bacteria.
Rev. Infect. Dis.
8:S279-S291.
|
| 32.
|
Tuomanen, E.,
R. Cozens,
W. Tosch,
O. Zak, and A. Tomasz.
1986.
The rate of killing of Escherichia coli by -lactam antibiotics is strictly proportional to the rate of bacterial growth.
J. Gen. Microbiol.
132:1297-1304[Medline].
|
| 33.
|
van der Linden, M. P.,
L. de Haan,
M. A. Hoyer, and W. Keck.
1992.
Possible role of Escherichia coli penicillin-binding protein 6 in stabilization of stationary-phase peptidoglycan.
J. Bacteriol.
174:7572-7578[Abstract/Free Full Text].
|
| 34.
|
van der Linden, M. P. G.,
L. de Haan,
O. Dideberg, and W. Keck.
1994.
Site-directed mutagenesis of proposed active-site residues of penicillin-binding protein 5 from Escherichia coli.
Biochem. J.
303:357-362.
|